2-aminopurine has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aarons, L; Graham, G; Kaiser, G; Looby, M; Matthews, I; Ogungbenro, K | 1 |
| Blumer, J; Hamed, K; Kaiser, G; Rodriguez, A; Sallas, W; Sánchez, PJ | 1 |
| Aleem, E; Kaldis, P; Kiyokawa, H | 1 |
| Field, HJ; Thackray, AM | 1 |
1 trial(s) available for 2-aminopurine and Body Weight
| Article | Year |
|---|---|
Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Antiviral Agents; Body Weight; Capsules; Child; Child, Preschool; Famciclovir; Female; Guanine; Herpes Simplex; Humans; Infant, Newborn; Male; Models, Biological | 2010 |
3 other study(ies) available for 2-aminopurine and Body Weight
| Article | Year |
|---|---|
Population pharmacokinetics and optimal design of paediatric studies for famciclovir.
Topics: 2-Aminopurine; Adult; Age Factors; Antiviral Agents; Area Under Curve; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Famciclovir; Female; Humans; Infant; Male; Models, Biological; Research Design; Time Factors | 2009 |
Cdc2-cyclin E complexes regulate the G1/S phase transition.
Topics: 2-Aminopurine; Animals; Body Weight; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Proliferation; Crosses, Genetic; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Female; Fibroblasts; G1 Phase; Gonads; Infertility; Interphase; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitosis; Ovarian Neoplasms; Pituitary Neoplasms; Protein Binding; RNA, Double-Stranded; S Phase; Sex Factors; Spleen; Thymus Gland; Transfection; Tumor Suppressor Proteins | 2005 |
Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Body Weight; Brain; Cell Culture Techniques; Dermatitis; Ear; Famciclovir; Female; Herpes Simplex; Herpesvirus 1, Human; In Situ Hybridization; Mice; Mice, Inbred BALB C; Neurons; Trigeminal Ganglion; Valacyclovir; Valine; Virus Latency | 1998 |